Samik Pharmaceutical Company LTD. (KOSDAQ:014950)

KOSDAQ:014950 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Feb 19, 2026	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	0.00	0.00	0.00
Debt / EBITDA Ratio	0.03	0.02	0.05
Debt / FCF Ratio	0.08	0.03	0.23
Net Debt / Equity Ratio	-0.36	-0.25	-0.18
Net Debt / EBITDA Ratio	-3.79	-2.55	-2.10
Net Debt / FCF Ratio	-9.43	-3.62	-9.80
Asset Turnover	-	0.91	-
Inventory Turnover	-	1.56	-
Quick Ratio	2.21	2.09	2.03
Current Ratio	3.40	3.27	3.23
Return on Equity (ROE)	-	7.02%	-
Return on Assets (ROA)	-	3.73%	-
Return on Invested Capital (ROIC)	8.08%	7.55%	6.10%
Return on Capital Employed (ROCE)	6.50%	6.80%	5.60%
Payout Ratio	7.65%	7.98%	4.73%
Buyback Yield / Dilution	-1.61%	-0.15%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.